Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-02-27 @ 10:33 AM
Study NCT ID:
NCT03920267
Status:
COMPLETED
Last Update Posted:
2025-04-17
First Post:
2019-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-21
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-27
First Submit QC Date:
None
Study First Post Date:
2019-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-15
Last Update Post Date:
2025-04-17
Last Update Post Date Type:
ACTUAL